搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 1 日前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
Harnessing Myokines To Preserve Muscle Power As We Age
Forbes· 3 日前The findings highlight the role of a protein called platelet-derived growth factor subunit B ...
Inflammasome Therapeutics Announces First Patient Dosed in Geographic Atrophy (GA) Clinical Trial
Bastillepost· 4 日前Inflammasome Therapeutics ( https://www.inflam.com ), a private company developing a new class ...
5-minute listening: How conjoined twins defied medical expectations
South China Morning Post· 4 日前Practise your English with our short listening exercises: play the audio; answer the questions; ...